Baloxavirmarboxil
Products Baloxavirmarboxil was approved in film-coated tablet form in Japan and the United States in 2018 and in many countries in 2020 (Xofluza). Structure and properties Baloxavirmarboxil (C27H23F2N3O7S, Mr = 571.5 g/mol) is a prodrug of baloxavir (synonym: baloxaviric acid). It is converted to the active drug by hydrolysis. It is practically insoluble in water. … Baloxavirmarboxil
